» Articles » PMID: 6556950

Nature of Antigens and Antibodies in Immune Complexes Isolated by Staphylococcal Protein A from Plasma of Melanoma Patients

Overview
Date 1983 Jan 1
PMID 6556950
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Immune complexes (IC) were isolated from plasma of melanoma patients by absorption to staphylococcal protein A and subsequent elution with MgCl2. The isolated ICs were purified by precipitation with polyethylene glycol and sucrose density gradient ultracentrifugation after radioiodination with 125I. The purified ICs were dissociated and radiolabeled antigen/antibody components were separated by ultracentrifugation at low pH (2.6). Under these conditions, about 72% radioactivity of the purified IC remained in the light-density region as a wide band. After neutralization, 26%-60% radioactivity in the region of 5S sedimentation bound to immobilized autologous immunoglobulins, as opposed to a maximum of 23% to immobilized immunoglobulins from human normal serum. Significant levels (73%-77%) of radioactivity in 7S region bound to rabbit anti-human IgG immunobeads. Immunoprecipitation of the antigen fraction by allogeneic anti-melanoma and rabbit anti-melanoma antibodies followed by SDS-polyacrylamide gel electrophoresis revealed the presence of a fetal antigen (FA) and a melanoma tumor-associated antigen (TAA). In addition, the presence of auto-antigen(s) was indicated by using autologous antibody in immunoprecipitation. Immunoglobulins (IgG) isolated from purified IC bound to cultured melanoma, sarcoma, and normal fibroblasts, although the binding to sarcoma and normal fibroblasts could be inhibited by preincubation of isolated IgG with soluble FA but not with soluble melanoma TAA. Thus, results of this investigation provide evidence that circulating IC in melanoma patients are composed of at least IgG and different antigens, and some of these antigens are produced by their tumor.

Citing Articles

Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.

Cohen-Solal J, Cassard L, Fournier E, Loncar S, Fridman W, Sautes-Fridman C Dermatol Res Pract. 2010; 2010:657406.

PMID: 20672001 PMC: 2905727. DOI: 10.1155/2010/657406.


Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.

Wong J, Aguero B, Gupta R, Morton D Cancer Immunol Immunother. 1988; 27(2):142-6.

PMID: 3046746 PMC: 11038578. DOI: 10.1007/BF00200019.

References
1.
Wright P, Hellstrom K, Hellstrom I, Bernstein I . Serotherapy of malignant disease. Med Clin North Am. 1976; 60(3):607-22. DOI: 10.1016/s0025-7125(16)31901-0. View

2.
Ruell P, Murray E, McCarthy W, Hersey P . Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma. Oncodev Biol Med. 1982; 3(1):1-12. View

3.
Gupta R, Irie R, Chee D, Kern D, Morton D . Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line. J Natl Cancer Inst. 1979; 63(2):347-56. View

4.
Herberman R, Bordes M, Lambert P, Luthra H, Robins R, Sizaret P . Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer. Int J Cancer. 1981; 27(5):569-76. DOI: 10.1002/ijc.2910270502. View

5.
Gupta R, Morton D . Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line. J Natl Cancer Inst. 1983; 70(6):993-1004. View